3D Signatures Inc. announced the appointment of Joost van der Mark as its Chief Business Officer (CBO), effective January 6, 2017, subject To Approve the TSXV. Mr. van der Mark brings more than two decades of executive experience to 3DS, having worked with several major international healthcare companies as well as earlier stage biotechnology and healthcare firms. Mr. van der Mark has an accomplished history of strategic operations, sales and marketing, clinical research, market access, business development and general management success in the global healthcare industry. He joins 3DS from BioSyent Inc., where he served as Vice President of Corporate Development with responsibility for business development and market access initiatives. Prior to joining BioSyent, Mr. van der Mark co-founded Orphan Canada, which subsequently sold its assets to Knight Therapeutics in 2014.